American Society of Hematology (ASH)/LinkedIn
Apr 15, 2026, 16:53
Sickle Cell Disease Care Varies by Region – ASH
American Society of Hematology (ASH) shared a post on LinkedIn:
”Sickle cell disease is the most common inherited blood disorder worldwide, yet patient experiences vary significantly by region.
Data from the Sickle Cell World Assessment Survey (SWAY) show that individuals in sub-Saharan Africa are less likely to know their sickle cell variant and use standard treatments, including over-the-counter pain medications, antibiotics, and folic acid.
They are also more likely to manage vaso-occlusive crises at home or rely on alternative approaches.
These results reflect variation in diagnosis, treatment patterns, and care delivery across regions.”
Stay updated with Hemostasis Today.
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026
-
Oct 17, 2026, 02:32Mohammed Al Sharif: Discussing Factor XIII Testing and Its Clinical Significance
-
Oct 17, 2026, 02:31Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention